dihexa retracted paper controversy Good news! 📰⁠ ⁠ Takeda announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy Retraction | The Transmitter: Neuroscience

We showed that cirrhotic (an IGF-1 deficiency condition) rats had diminished amino acid and glucose intestinal absorption [114, 194, 195] and that IGF-1 replacement therapy was able to restore both alterations, suggesting a role of IGF-1 in the position of transporters [196]

The concern isnt just that youll develop antibodies against the peptide itselfits that those antibodies might cross-react with your own endogenous proteins

& Davies, M

Have a question

A common pattern is a Myers Cocktail (which already has B12) once or twice a month, plus a quick standalone B12 shot in between if energy dips during a heavy stretch

collagenase clostridium histolyticum-aaes), a new treatment that recently received FDA approval to treat cellulite in the buttocks of women